TMCI Treace Medical Concepts: Utang jangka cendhak perusahaan

Logo perusahaan publik Treace Medical Concepts (TMCI)

Serving as an assessment tool, the short-term liabilities chart for Treace Medical Concepts (TMCI) recorded a value of 0.01, while management revises its sales approach due to competitive pressure and seeks to reduce operating expenses. The business specializes in creating innovative stop correction methodologies, ensuring steady demand for its own patented components. Such fundamental advantages make the company a promising player in the niche of highly specialized medical equipment.

TMCI (Treace Medical Concepts, Inc.) riwayat Utang jangka cendhak perusahaan saka 04.07.2022 nganti 30.10.2026
Produk sing diprodhuksi treace.com

Liquidity management is critical for Treace Medical Concepts (TMCI), which is implementing the Lapiplasty standard in foot surgery. This indicator aggregates all credit obligations with a maturity of up to one year. Analyzing the short-term debt burden allows for an assessment of the risk of cash flow gaps. The payment dynamics confirm the company's ability to finance the expansion of its innovations. The reduction in debt indicates high operational resilience of the business.

Pesaing utama

Boston Scientific Corporation - Utang jangka cendhak perusahaan|Edwards (EW) - Kewajiban jangka cendhak perusahaan|RMD: Utang jangka cendhak perusahaan|PODD - Gunggunge utang jangka cendhak|ZBH (Zimmer Biomet Holdings Inc) - Utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan coopercos.com|Utang jangka cendhak perusahaan Align Technology (ALGN)|Utang jangka cendhak perusahaan GMED (Globus Medical Inc)|Utang jangka cendhak perusahaan TMDX (transmedics.com)|Gunggunge utang jangka cendhak Alphatec Corp (ATEC)|AORT: Kewajiban jangka cendhak perusahaan|Kewajiban jangka cendhak ENOV|IART: Utang jangka cendhak perusahaan|Utang jangka cendhak Establishment Labs Corp (ESTA)|BBNX (Beta Bionics Corp) - Utang jangka cendhak perusahaan|Tanggungan utang jangka cendhak perusahaan IRMD (IRADIMED Inc.)|Kewajiban jangka cendhak perusahaan EMBC (Embecta Corp.)|TNDM (tandemdiabetes.com) - Silihan lan utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan Axogen AXGN|SIBN - Kewajiban jangka cendhak perusahaan|Orthofix International - Utang jangka cendhak perusahaan|Utang jangka cendhak Bioventus Global|KIDS: Utang jangka cendhak perusahaan|Tanggungan utang jangka cendhak perusahaan SRTA|CARL (Carlsmed) - Utang jangka cendhak perusahaan|RxSight Inc (RXST) - Gunggunge utang jangka cendhak|Utang jangka cendhak perusahaan CLPT|Kewajiban jangka cendhak perusahaan Stereotaxis Corporation STXS|Utang jangka cendhak perusahaan STIM (Neuronetics, Inc.)|Utang jangka cendhak perusahaan sightsciences.com SGHT|OBIO - Utang jangka cendhak perusahaan|ANIK: Utang jangka cendhak perusahaan|NSPR (InspireMD Corp) - Kewajiban jangka cendhak perusahaan|Jin Medical - Silihan lan utang jangka cendhak perusahaan|VANI (Vivani Medical Inc) - Utang jangka cendhak perusahaan|Utang jangka cendhak Xtant Medical Inc XTNT|Utang jangka cendhak perusahaan NeuroOne Medical Technologies Corporation (NMTC)|modular-medical.com (MODD) - Tanggungan jangka cendhak|Myomo, Inc - Kewajiban jangka cendhak perusahaan|Utang jangka cendhak perusahaan Envoy Medical Inc COCH|Vivos Therapeutics - Utang jangka cendhak perusahaan|Gunggunge utang jangka cendhak envveno.com NVNO|sintx.com (SINT) - Utang jangka cendhak perusahaan|Kewajiban jangka cendhak TNON (Tenon Medical Inc.)|Utang jangka cendhak perusahaan ReWalk Robotics Ltd|Kewajiban jangka cendhak perusahaan Autonomix (AMIX)|Utang jangka cendhak perusahaan IVF|BBLG - Utang jangka cendhak|Utang jangka cendhak perusahaan Axonics AXNX|BIOL: Tanggungan utang jangka cendhak perusahaan|DYNT: Kewajiban jangka cendhak perusahaan|Paragon 28, Inc. - Gedhene kewajiban jangka cendhak|INVO (invobioscience.com) - Kewajiban jangka cendhak perusahaan